Perceptive Advisors Buys $7.5M of Immatics Shares at $8.69
IMTX sits 86% above its 52-week low of $5.05.
Summary
Perceptive Advisors bought $7.5 million of Immatics shares at $8.69, increasing its stake to 11.2 million shares.
Key Events · Ownership and Investor Activity · IMTX
-
Perceptive Advisors Buys $7.5M of Immatics
Perceptive Life Sciences Master Fund Ltd. purchased 863,060 ordinary shares at $8.69 per share for $7,499,991.40 on August 26, 2026.
-
Stake Increases to 11.2M Shares
Post-transaction holdings total 11,246,516 shares, held indirectly through the Master Fund managed by Perceptive Advisors LLC.
-
Follows $150M Offering Close
The purchase comes one day after Immatics closed a $150 million underwritten offering, netting $161.1 million after full exercise of the underwriters' option.
-
Director-Affiliated Fund
Joseph Edelman, a director of Immatics, is the managing member of Perceptive Advisors LLC, which serves as investment manager to the Master Fund.
Analysis · IMTX · Life Sciences
Perceptive Advisors, through its Master Fund, purchased 863,060 shares of Immatics for $7.5 million at $8.69 per share on August 26, 2026. This is a significant open-market buy by a director-affiliated investment fund, representing roughly 0.53% of the company's market cap. The purchase comes just one day after Immatics closed a $150 million underwritten offering, suggesting continued institutional conviction in the company's clinical pipeline and cash position.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IMTX was trading at $9.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $5.05 to $12.41. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.